Your browser doesn't support javascript.
loading
Cancer associated fibroblast FAK regulates malignant cell metabolism.
Demircioglu, Fevzi; Wang, Jun; Candido, Juliana; Costa, Ana S H; Casado, Pedro; de Luxan Delgado, Beatriz; Reynolds, Louise E; Gomez-Escudero, Jesus; Newport, Emma; Rajeeve, Vinothini; Baker, Ann-Marie; Roy-Luzarraga, Marina; Graham, Trevor A; Foster, Julie; Wang, Yu; Campbell, James J; Singh, Rajinder; Zhang, Penglie; Schall, Thomas J; Balkwill, Frances R; Sosabowski, Jane; Cutillas, Pedro R; Frezza, Christian; Sancho, Patricia; Hodivala-Dilke, Kairbaan.
Afiliación
  • Demircioglu F; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Wang J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Candido J; Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Costa ASH; MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
  • Casado P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • de Luxan Delgado B; Centre for Stem Cells in Cancer and Ageing, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Reynolds LE; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Gomez-Escudero J; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Newport E; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Rajeeve V; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Baker AM; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Roy-Luzarraga M; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Graham TA; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Foster J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Wang Y; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA.
  • Campbell JJ; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA.
  • Singh R; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA.
  • Zhang P; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA.
  • Schall TJ; ChemoCentryx Inc., 850 Maude Ave, Mountain View, CA94043, USA.
  • Balkwill FR; Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Sosabowski J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Cutillas PR; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Frezza C; MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
  • Sancho P; Centre for Stem Cells in Cancer and Ageing, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Hodivala-Dilke K; IIS Aragon, Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain.
Nat Commun ; 11(1): 1290, 2020 03 10.
Article en En | MEDLINE | ID: mdl-32157087
ABSTRACT
Emerging evidence suggests that cancer cell metabolism can be regulated by cancer-associated fibroblasts (CAFs), but the mechanisms are poorly defined. Here we show that CAFs regulate malignant cell metabolism through pathways under the control of FAK. In breast and pancreatic cancer patients we find that low FAK expression, specifically in the stromal compartment, predicts reduced overall survival. In mice, depletion of FAK in a subpopulation of CAFs regulates paracrine signals that increase malignant cell glycolysis and tumour growth. Proteomic and phosphoproteomic analysis in our mouse model identifies metabolic alterations which are reflected at the transcriptomic level in patients with low stromal FAK. Mechanistically we demonstrate that FAK-depletion in CAFs increases chemokine production, which via CCR1/CCR2 on cancer cells, activate protein kinase A, leading to enhanced malignant cell glycolysis. Our data uncover mechanisms whereby stromal fibroblasts regulate cancer cell metabolism independent of genetic mutations in cancer cells.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína-Tirosina Quinasas de Adhesión Focal / Fibroblastos Asociados al Cáncer / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína-Tirosina Quinasas de Adhesión Focal / Fibroblastos Asociados al Cáncer / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article